Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001414

Drug Information
NameOxatomide    
SynonymsOxatomidum [INN-Latin]; BAS 01509783; Celtect (TN); R 35443; Oxatomida [INN-Spanish]; R 35,443; BIM-0024581.P001; UNII-J31IL9Z2EE; MLS000028549; 60607-34-3; AKOS000507212; McN-JR 35443; NCGC00015774-03; BRN 4724760; CHEMBL13828; D01773; C27H30N4O; Oxatomidum; 2H-Benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-; Bio-0750; C015408; NCGC00015774-01; 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one; R-35443; O 9387; 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone; Lopac-O-9387; EINECS 262-320-9; Lopac0_000924; KW-4354; Oxatomida; KW 4354; EU-0100924; Celtect; LS-33365; NSC309710; 1-[3-(4-Benzhydryl-piperazin-1-yl)-propyl]-1,3-dihydro-benzoimidazol-2-one; CHEBI:112890; Tinset; 2H-Benzimidazol-2-one, 1-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-; 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-2-benzimidazolinone; Oprea1_338592; NCGC00094235-01; Oxetal; O9387_SIGMA; CID4615; 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one; Oxatomide (JAN/USAN/INN); NCGC00015774-02; R35443; 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one; I06-0696; MolPort-001-964-500; HMS2089N07; CBMicro_024634; SMR000058301; 2H-Benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-; AC1L1IKA; Oxatomide (tinset); Oxatomide [USAN:BAN:INN:JAN]; NCGC00094235-02; oxatomide; Oxatimide    
CompanyJanssen Pharmaceutica    
IndicationHay feverApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Allergic Agents    
CAS NumberCAS 60607-34-3
FormularC27H30N4O    
PubChem Compound IDCID 4615.    
PubChem Substance IDSID 183792.    
SuperDrug ATC IDR06AE06;    
SuperDrug CAS ID060576138;    
TargetHistamine H1 receptorAntagonist[1][2]
Ref 1Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization. J Pharmacol Sci. 2008 May;107(1):66-79. Epub 2008 Apr 29. To Reference
Ref 2Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J Allergy Clin Immunol. 2003 Oct;112(4 Suppl):S78-82. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543